We examined the influence of 8-hydroxy-2-di-n-propylamino tetralin (8- 
Adrenal steroids regulate diverse processes and systems in the brain. Several studies have indicated that the activation of the hypothalamic-pituitary-adrenal axis changes the serotonin (5-hydroxytryptamine, 5-HT) function in the brain. The 5-HT receptor subtypes, particularly 5-HT 2A and 5-HT 1A receptors, have been postulated to play an important role in the pathogenesis of depression. 1, 2) Some clinical studies have demonstrated increases in the number of 5-HT 2A receptorbinding sites in the postmortem brains of both suicides and depressed subjects. [3] [4] [5] Our previous studies have already reported that chronic adrenocorticotropic hormone (ACTH) treatment increases the wet-dog shake response induced by (Ϯ)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), 5-HT 2A receptor agonist. 6 ) Thus, we suggested that chronic ACTH-treated rats could induce the hyperactivity of the 5-HT 2A receptor via the activation of the hypothalamicpituitary-adrenal axis.
On the other hand, numerous investigations have demonstrated interactions between the brain 5-HT 1A receptor function and the hypothalamic-pituitary-adrenal axis. It was reported that chronic treatment with corticosterone decreased 5-HT 1A receptor binding and the levels of 5-HT 1A receptor mRNA in the hippocampus. 7, 8) We demonstrated that hypercorticism, which raises circulating corticosterone levels, decreased the 5-HT 1A receptor binding in hippocampal membranes. 9) Thus, the enhancement of the hypothalamic-pituitary-adrenal axis produced dysfunction of the 5-HT 1A receptor mechanism.
Furthermore, several studies have suggested that there are functional interactions from 5-HT 2A receptor function to 5-HT 1A receptor function. It has been reported that 8-hydroxy-2-di-n-propylamino tetralin (8-OH-DPAT), 5-HT 1A receptor full agonist, inhibited DOI-induced head twitch behavior in naive rats. [10] [11] [12] [13] These results supported the hypothesis that 5-HT 1A receptors exert an inhibitory control over the activation of 5-HT 2A receptors. Such interactions may play an important role in the mechanism of action of antidepressant drugs. [14] [15] [16] As previous studies have been used for normal rats, the model of the hypothalamic-pituitary-adrenal axis activation is interesting from the viewpoint of the mechanism of interaction between 5-HT 2A and 5-HT 1A receptor function, or of the action of the 5-HT 1A receptor agonist.
In the present study, we examined the influence of 8-OH-DPAT on the effect of chronic ACTH treatment increasing the DOI-induced wet-dog shakes, and also examined 8-OH-DPAT-induced hypothermia and flat body posture, as an index reflective of 5-HT 1A receptor function.
MATERIALS AND METHODS

Animals
Male Wistar rats (Charles River, Japan) with an initial weight of 180-230 g were utilized in this study. Rats were kept on a constant light-dark cycle (light 07:00-19:00 h), with standard laboratory food and tap water in an air-conditioned room (23Ϯ1°C with approximately 60% humidity).
Drugs The following drugs were used in this study: (Ϯ)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI: Research Biochemicals Inc., South Natick, MA, U.S.A.), (Ϯ)-8-hydroxy-2-di-n-propylamino tetralin hydrobromide (8-OH-DPAT: Research Biochemicals Inc., South Natick, MA, U.S.A.), ketanserin tartrate (Sigma-Aldrich Co., St. Louis, MO, U.S.A.) and ACTH-(1-24)-zinc (Cortrosyn-Z: Daiichi Seiyaku, Tokyo, Japan). 8-OH-DPAT, DOI and ketanserin were dissolved in saline. Rats were injected with 8-OH-DPAT, DOI and ketanserin at 2 ml/kg body weight. ACTH (Cortrosyn-Z) was injected subcutaneously once daily (9:00 to 10:00) at a dose of 100 mg/rat (injection volume was The DOI-induced wet-dog shake response was induced 24 h after the administration of the last dose of ACTH. Two animals were put into clear plastic cages (22ϫ38ϫ18 cm) at an ambient temperature of 23Ϯ1°C for at least 2 h before drug administration. The animals were treated with DOI (1 mg/kg, s.c.) and returned to their cages. Immediately after injection, the number of wet-dog shakes was recorded over a 30-min period, as reported previously. 17) Measurement of 5-HT 1A Receptor-Mediated Behavioral Response: 8-OH-DPAT-induced hypothermia and flat body posture were observed in the same rats 24 h after the administration of the last dose of ACTH. Adaptation to the environment was likewise the measurement of the 5-HT 2A receptor-mediated behavioral response. Their body temperature was measured with a thermision probe (connected to an electronic thermometer) inserted 2 cm into the rectum. Their temperature was measured immediately before drug administration. The animals were then treated with 8-OH-DPAT and returned to their cages. The hypothermic response to 8-OH-DPAT was calculated from the decrease in body temperature. Flat body posture observation periods of 1 min were initiated 5 min after the drug injection, and this observation was repeated every 5 min over a period of 30 min. Flat body posture was scored, using the ranked intensity scale (0ϭabsent, 1ϭequivocal, 2ϭpresent, 3ϭmarked) described by Tricklebank et al. 18) Scores were summed for 6 observation periods. Their body temperature was measured again 30 min following 8-OH-DPAT administration.
Experiments Statistics Values are expressed as the meansϮS.E.M. The data were analyzed by one-way analysis of variance (ANOVA), and the group means were compared using Student's t-test or Dunnett's test for multiple comparisons. Flat body posture was analyzed with Wilcoxon rank sum test. Probability values less than 0.05 were considered to show a significant difference. RESULTS Experiment 1. The Effect of Ketanserin on the DOI-Induced Wet-Dog Shake Response in Rats: DOI (0.3-3 mg/kg, s.c.) produced a dose-dependent increase in wet-dog shakes (F (3, 20) ϭ8.27, pϽ0.01) (Fig. 1A) . Ketanserin (0.03-0.3 mg/kg, s.c.) decreased the wet-dog shakes induced by DOI (1 mg/kg, s.c.) in a dose-dependent manner (F (3, 20) ϭ 8.57, pϽ0.01) (Fig. 1B) .
Experiment 2. The Effects of ACTH on the DOI-Induced Wet-Dog Shake Response in Rats: Chronic treatment with ACTH (100 mg/rat, s.c.) for 1-14 d chronologically increased the DOI (1 mg/kg, s.c.)-induced wet-dog shake response (F (4, 35) ϭ4.66, pϽ0.01) (Fig. 2) .
Experiment 3. The Effect of ACTH on the Inhibitory Effect of 8-OH-DPAT on the DOI-Induced Wet-Dog Shake Response in Rats: 8-OH-DPAT significantly inhibited the DOI (1 mg/kg, s.c.)-induced wet-dog shake response in naive rats (F (3, 28) ϭ12.80, pϽ0.01) (Fig. 3) . On the other hand, the inhibitory effect of 8-OH-DPAT on the DOI-induced wet-dog shake response was likewise observed in rats treated with ACTH (100 mg/rat, s.c.) for 14 d (F (3, 20) ϭ12.20, pϽ0.01) (Fig. 3) . (Fig. 4) .
Discussion In this study, we demonstrated that chronic treatment with ACTH produced changes in brain serotonergic neural function, affecting the 5-HT 2A and 5-HT 1A receptor function, and the behavioral interaction of 5-HT 2A and 5-HT 1A receptor function. The one major finding was that the inhibitory effect of 8-OH-DPAT on the DOI-induced wet-dog shake response was observed by the chronic administration of ACTH for 14 d. Numerous investigations have demonstrated a possible interaction between 5-HT 2A and 5-HT 1A receptor function in naive rats. It had been reported that the DOI-induced wet-dog shake response and head twitch response were inhibited by the administration of 8-OH-DPAT. [10] [11] [12] [13] It is reasonable to suggest that activation of the 5-HT 1A receptor function exerts an inhibitory effect on the 5-HT 2A receptor function via the 5-HT 1A receptor function.
We observed that plasma corticosterone levels in rats following a 14-d chronic ACTH treatment (100 mg/d, s.c.) were significantly higher than those in saline treatment rats (saline 1.1Ϯ0.2 mg/dl; ACTH 13.9Ϯ3.0 mg/dl). We thereby demonstrated that chronic ACTH treatment in rats produced a significant elevation in corticosterone levels compared with nontreated controls, a condition termed hypercorticism. Furthermore, chronic ACTH treatment, a treatment that up-regulates the hypothalamic-pituitary-adrenal axis, inhibited the 8-OH-DPAT-induced hypothermia and flat body posture in the present study. Numerous investigations have demonstrated a possible interaction between the 5-HT 1A receptor and the hypothalamic-pituitary-adrenal axis. We previously reported that binding of [ 9) An autoradiographic study showed that chronic exposure to high levels of corticosterone decreased the binding at 5-HT 1A receptors in the dentate gyrus and CA4 hippocampus region in rats. 7) Additionally, chronic but not acute treatment with corticosterone decreased 5-HT 1A receptor binding in rat CA1 hippocampus region (in the ventral part only) and the dentate gyrus. 8) Regarding 5-HT 1A receptor binding, the general consensus is that the chronically elevated corticosterone down-regulates 5-HT 1A receptor binding in the hippocampus. In the present study, the inhibitory effect of 8-OH-DPAT on the DOI-induced wet-dog shake response was not inhibited by the chronic administration of ACTH. With respect to the inhibitory effect of 5-HT 1A receptors on 5-HT 2A receptors, we assumed that the 5-HT 1A receptor-mediated action was not inhibited by the enhancement of the hypothalamic-pituitary-adrenal axis. Namely, these studies thus suggest that 5-HT 1A receptor function is not always suppressed on the activation of the hypothalamic-pituitary-adrenal axis.
In this study, the chronic treatment of ACTH inhibited the 5-HT 1A receptor function. However, the inhibitory effect of the 5-HT 2A receptor function due to the 5-HT 1A receptor stimulation was not inhibited by ACTH. These findings suggest that the inhibitory effect of the 5-HT 2A receptor due to the 5-HT 1A receptor may be related to some aspect of the antidepressive effect of the 5-HT 1A receptor agonist. 
